Sign inJoin waitlistJoin the waitlist

Harold Katner

Atrium Health Navicent Infectious Disease Fellowship Director · Atrium Health Navicent The Medical Center

Credentials: · · · ·

History

Atrium Health Navicent Infectious Disease Fellowship · Atrium Health Navicent The Medical Center
Present
Atrium Health Navicent The Medical Center Fellowship
Present
Division /Fellowship Fellowship · Atrium Health Navicent The Medical Center
Present

Center
1986–1988
Internal Medicine
University Medical Center
1983–1986
Ochsner Clinic Foundation
1980–1983
Louisiana State University School of Medicine in New Orleans
1976–1980
University of New Orleans
1972–1976

Research

Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3…
The Lancet HIV · 2021 · 120 citations
Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
AIDS and Behavior · 2020 · 78 citations
Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia
Journal of acquired immune deficiency syndromes · 2020 · 65 citations

GP
George Pankey
6 papers
JD
Joseph Dalovisio
4 papers
SB
Stephen Baynham
4 papers · 3 as a resident
Mahi Ashwath
3 papers · 3 as a resident
AM
Anthony Mills
2 papers
Hemant Goyal
2 papers
RD
Richard Deshazo
2 papers
RH
Robert Hash
2 papers
AS
Alexandra Samborski
1 paper
Amy Colson
1 paper
Angela Caliendo
1 paper
BT
Ben Treen
1 paper · 1 as a resident

Clinical trials

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Site PI · Recruiting · Phase 2
ViiV Healthcare
2026–2028